Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer. Zeng L, Tong F, Xu X, Song L, et al. Lung Cancer 2025;207:108684.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zeng L, Tong F, Xu X, Song L, et al. Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer. Lung Cancer 2025;207:108684.
PMID: 40752090